ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2012
Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impacts on health outcomes and on resources utilization for anticancer drugs injection at home, a complex intervention: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Pooled it
- Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.Breast cancer research and treatment · 2020Trial
- Insights From a User Experience-Focused Virtual Study on the Feasibility and Challenges of Decentralized Clinical Trials.Clinical and translational science · 2025Article
- Systematic literature review of asthma biologic self-administration enhanced by a patient perspective.The journal of allergy and clinical immunology. Global · 2024Article
- Parenteral medication use in hospital at home: Challenges and opportunities.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024Article
- Onco@home: comparing the costs and reimbursement of cancer treatment at home with the standard of care.Archives of public health = Archives belges de sante publique · 2024Article
- Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital in Rome.Mediterranean journal of hematology and infectious diseases · 2024Article
- Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Fit for Duty: Lessons Learned from Outpatient and Homebound Hematopoietic Cell Transplantation to Prepare Family Caregivers for Home-Based Care.Transplantation and cellular therapy · 2023Article
- Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône-Alps region in France.International journal of technology assessment in health care · 2023Article
- Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative review.Mediastinum (Hong Kong, China) · 2022Review
- Evaluation of adverse events and health-related quality of life in patients with colorectal cancer receiving ambulatory home-based chemotherapy in Thailand.Nursing open · 2021Observational
- Creating and Validating a Predictive Model for Suitability of Hospital at Home for Patients With Solid-Tumor Malignancies.JCO oncology practice · 2021Observational
- Safety and family satisfaction of a home-delivered chemotherapy program for children with cancer.Italian journal of pediatrics · 2021Article
- Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care.Frontiers in oncology · 2020Article
- Article
- Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016Article
- Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer.Oncology and therapy · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study was to evaluate feasibility, safety, perception, and costs of home care for the administration of intensive chemotherapies.
methodsPatients receiving sequential chemotherapy in an inpatient setting, living within 30 km of the hospital, and having a relative to care for them were offered home care treatment. Chemotherapy was administered by a portable, programmable pump via an implantable catheter. The main endpoints were safety, patient's quality of life [Functional Living Index-Cancer (FLIC)], satisfaction of patients and relatives, and costs.
resultsTwo hundred days of home care were analysed, representing a total of 46 treatment cycles of intensive chemotherapy in 17 patients. Two cycles were complicated by technical problems that required hospitalisation for a total of 5 days. Three major medical complications (heart failure, angina pectoris, and major allergic reaction) could be managed at home. Grades 1 and 2 nausea and vomiting occurring in 36% of patients could be treated at home. FLIC scores remained constant throughout the study. All patients rated home care as very satisfactory or satisfactory. Patient benefits of home care included increased comfort and freedom. Relatives acknowledged better tolerance and less asthenia of the patient. Home care resulted in a 53% cost benefit compared to hospital treatment (€420 ± 120/day vs. €896 ± 165/day).
conclusionAdministration of intensive chemotherapy regimens at home was feasible and safe. Quality of life was not affected; satisfaction of patients and relatives was very high. A psychosocial benefit was observed for patients and relatives. Furthermore, a cost-benefit of home care compared to hospital treatment was demonstrated.
Indexed as
Identifiers
21384139What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.